(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will evaluate the effects of the drug tolterodine on nocturia (having to get up at night to urinate). Menopausal women 45-65 who have had no monthly period for at least six months, and who have had at least 14 episodes of nocturia per week related to overactive bladder, stress incontinence, or polyuria (release of abnormally large amounts of urine each day) may qualify.
The research site is in Boston, Mass.
This study will compare an aminolevulinic acid therapy combined with a laser, versus a laser alone, in the reduction of acne lesions on the face. Caucasians 18 or older may be eligible who have moderate acne, have not been diagnosed with facial psoriasis, seborrheic dermatitis, perioral dermatitis (around the mouth rash) or rosacea, and do not have a history of cold sores.
The research site is in New York City.
Systemic Lupus Erythematosus
People with systemic lupus erythematosus (SLE) may participate in this study if they are ages 18-70, do not have liver disease or allergies to shellfish, and haven't received any type of vaccination within 30 days of study participation.
The research site is in Birmingham, Ala.
Copyright 2007 Thomson CenterWatch. All rights reserved.